APA

Langkjer S. T., Kenholm J., Jensen J. D., Wedervang K., Brixen A. T., Grunnet M., Stenbygaard L., Gilje B., Danø H., Glavicic V., Jacobsen E. H., Brems-Eskildsen A. S., Kruse H. L., Dongsgaard T., Neimann J. & Geisler J. (20200124). The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer. : Future oncology (London, England).

Chicago

Langkjer Sven Tyge, Kenholm Julia, Jensen Jeanette Dupont, Wedervang Kim, Brixen Annette Torbøl, Grunnet Mie, Stenbygaard Lars, Gilje Bjørnar, Danø Hella, Glavicic Vesna, Jacobsen Erik Hugger, Brems-Eskildsen Anne Sofie, Kruse Helle Lemvig, Dongsgaard Trine, Neimann Jeppe and Geisler Jürgen. 20200124. The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer. : Future oncology (London, England).

Harvard

Langkjer S. T., Kenholm J., Jensen J. D., Wedervang K., Brixen A. T., Grunnet M., Stenbygaard L., Gilje B., Danø H., Glavicic V., Jacobsen E. H., Brems-Eskildsen A. S., Kruse H. L., Dongsgaard T., Neimann J. and Geisler J. (20200124). The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer. : Future oncology (London, England).

MLA

Langkjer Sven Tyge, Kenholm Julia, Jensen Jeanette Dupont, Wedervang Kim, Brixen Annette Torbøl, Grunnet Mie, Stenbygaard Lars, Gilje Bjørnar, Danø Hella, Glavicic Vesna, Jacobsen Erik Hugger, Brems-Eskildsen Anne Sofie, Kruse Helle Lemvig, Dongsgaard Trine, Neimann Jeppe and Geisler Jürgen. The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer. : Future oncology (London, England). 20200124.